COVID-19

Accelerating the rapid launch of COVID-19 vaccine and treatment trials with confidence.

While the COVID-19 pandemic has transitioned to its endemic stage, the need for developing new vaccines, boosters and treatments continues. Get started with bold scientific thinking from the clinical and regulatory teams that supported more than 70 COVID-19 clinical trials and consulting projects since the start of the pandemic.

Our global team of experts are available to assist with clinical trial design, clinical trial conduct, and all the regulatory and safety support required to keep your clinical development programs on track. And we offer proven virtual or decentralized trial solutions to ease the burden of patient participation.

Developing a COVID-19 treatment or vaccine?

Home > Therapeutic areas > COVID-19

COVID19_TA page

Study Design and Methodology that works
Development of regulatory strategy, expedited pathways, and regulatory agency interactions
Clinical program planning, inclusive of statistical planning and analysis 
Agile patient recruitment strategies to support virtual trial and hybrid approaches
Marketing Application Preparation and Publishing
Post-Market Pharmacovigilance Ensure Safety

News: Congratulations on COVID-19 Vaccine Approval

Veristat study collaboration with HIPRA leads to EMA approval of BIMERVAX® COVID-19 vaccine, the first bivalent recombinant protein vaccine to be authorized in the EU and the first human health vaccine to be designed and developed in Spain.